Dapsone and Ramelteon drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported only by a few people who take Dapsone and Ramelteon together.
The phase IV clinical study analyzes what interactions people who take Dapsone and Ramelteon have. It is created by eHealthMe based on reports of 3 people who take the same drugs from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
3 people who take Dapsone and Ramelteon together, and have interactions are studied.
What is Dapsone?
Dapsone has active ingredients of dapsone. It is often used in dermatitis herpetiformis. eHealthMe is studying from 9,977 Dapsone users for its effectiveness, alternative drugs and more.
What is Ramelteon?
Ramelteon has active ingredients of ramelteon. It is often used in insomnia. eHealthMe is studying from 1,095 Ramelteon users for its effectiveness, alternative drugs and more.
Number of Dapsone and Ramelteon reports submitted per year:
Common Dapsone and Ramelteon drug interactions by gender *:
female:
- Hypervolaemia
- Pneumonia
- Aortic stenosis
- Sinusitis
- Streptococcal bacteraemia
male:
n/a
Common Dapsone and Ramelteon drug interactions by age *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
n/a
60+:
- Hypervolaemia
- Pneumonia
- Aortic stenosis
- Sinusitis
- Streptococcal bacteraemia
* Approximation only. Some reports may have incomplete information.
Do you take Dapsone and Ramelteon?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Semira ZA, Zulfkar Q, Sameem F, "Livedo reticularis associated with dapsone therapy in a patient with chronic urticaria", Indian journal of pharmacology, 2014 Jan .
Related studies
Alternative drugs to, pros and cons of the 2 drugs:
Browse all drug interactions of Dapsone and Ramelteon:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Dapsone side effects:
- Fever: 754 reports
- Drug ineffective: 665 reports
- Fatigue (feeling of tiredness): 610 reports
- Rashes (redness): 579 reports
- Pneumonia: 506 reports
- Pain: 444 reports
- Weakness: 435 reports
Browse all side effects of Dapsone:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Dapsone interactions:
- Dapsone and Prednisone: 2,039 reports
- Dapsone and Fluconazole: 954 reports
- Dapsone and Aspirin: 837 reports
- Dapsone and Omeprazole: 735 reports
- Dapsone and Tacrolimus: 663 reports
- Dapsone and Mycophenolate mofetil: 658 reports
- Dapsone and Revlimid: 647 reports
- Dapsone and Methotrexate: 638 reports
- Dapsone and Gabapentin: 617 reports
- Dapsone and Prednisolone: 616 reports
Browse all interactions between Dapsone and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Ramelteon interactions:
- Ramelteon and Decadron: 137 reports
- Ramelteon and Furosemide: 118 reports
- Ramelteon and Zolpidem: 113 reports
- Ramelteon and Lansoprazole: 112 reports
- Ramelteon and Famotidine: 102 reports
Browse all interactions between Ramelteon and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on dapsone and ramelteon (the active ingredients of Dapsone and Ramelteon, respectively), and Dapsone and Ramelteon (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Dapsone and Ramelteon.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Xarelto and Sepsis - a second ago
- Xarelto and General Physical Health Deterioration - 12 seconds ago
- Bystolic and Robaxin drug interaction - 22 seconds ago
- Xarelto and Joint Swelling - 25 seconds ago
- Xarelto and Paraesthesia - 40 seconds ago
- Hydrochlorothiazide and Farxiga drug interaction - 47 seconds ago
- Xarelto and Gait Disturbance - 53 seconds ago
- Xarelto and Blood Urine Present - a minute ago
- Xarelto and Respiratory Acidosis - a minute ago
- Minoxidil and Retinal Vessel Occlusion - a minute ago